Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mexico pioneers medical technology training programme:

This article was originally published in Clinica

Executive Summary

Mexico has launched a programme to train doctors and paramedics in the use of innovative medical technology was launched last week. Skin surgery was the subject of the first course of the national medical techniques development centre (CEDDEM). The programme also features: laparoscopic and conventional surgery; gastrointestinal, urological and lung endoscopy; and airway management. The CEDDEM, based in Tlalpan (Mexico federal district), is a joint private and public initiative. Its leading private-sector sponsor is the AstraZeneca Foundation, which contributed Mex$7m (US$630,000) towards the construction and equipping of the new facilities. The new programme was described by Dr Fernando Gabilondo, director general of the national medical and nutritional sciences institute, as a pioneering model for the rest of Latin America.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT054270

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel